Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC.
D000276:Adjuvants, Immunologic; D000818:Animals; D002266:Carboxymethylcellulose Sodium / Q000276:immunology / Q000494:pharmacology* / Q000031:analogs & derivatives; D006968:Hypersensitivity, Delayed; D007939:Leukemia L1210 / Q000276:immunology; D008297:Male; D008545:Melanoma / Q000276:immunology; D008747:Methylcellulose / Q000031:analogs & derivatives*; D051379:Mice; D008815:Mice, Inbred Strains; D010455:Peptides / Q000494:pharmacology*; D011070:Poly I-C / Q000276:immunology / Q000494:pharmacology*; D011107:Polylysine / Q000276:immunology / Q000494:pharmacology* / Q000031:analogs & derivatives; D011108:Polymers / Q000494:pharmacology*; D011713:Pyran Copolymer / Q000276:immunology / Q000494:pharmacology*; D014612:Vaccines / Q000276:immunology*
D000276:Adjuvants, Immunologic; D010455:Peptides; D011108:Polymers; D014612:Vaccines; D011107:Polylysine; D011713:Pyran Copolymer; C019531:poly ICLC; D008747:Methylcellulose; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C